Pure Global

Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway - Trial NCT05721742

Access comprehensive clinical trial information for NCT05721742 through Pure Global AI's free database. This phase not specified trial is sponsored by Nova Scotia Health Authority and is currently Not yet recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 76 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05721742
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05721742
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway

Study Focus

virtually administered dietitian consults for IBS patients.

Interventional

other

Sponsor & Location

Nova Scotia Health Authority

Timeline & Enrollment

N/A

Mar 01, 2023

Mar 01, 2024

76 participants

Primary Outcome

IBS Symptom Severity,IBS Symptom Severity,IBS Specific Quality of Life,IBS Specific Quality of Life,Patient Quality of Life,Patient Quality of Life,Total number Inpatient services in the last 3 months,Total number Inpatient services in the last 3 months,Total number Outpatient appointments in the last 3 months,Total number Outpatient appointments in the last 3 months,Volume of referrals to Dietician,Volume of referrals to Online Group Session,Patient satisfaction with the Virtual Dietician led 1 on 1 education session,Volume of 1 on 1 dietary consults completed,Number of online modules competed for Online Group Session,Number of sessions compared to proposed,Number of Modules accessed,Number of Modules completed,Percentage participation in group session,Quality Adjusted Life Years

Summary

Irritable bowel syndrome is a functional bowel disorder that affects many Canadians. The
 syndrome involves abdominal pain and change in frequency or form of bowel movements, and
 these symptoms can lead to a decreased quality of life for patients. Primary care physicians
 are dissatisfied with current referral processes, and patients may wait a long time to
 receive the correct diagnosis. Diet is known to exacerbate symptoms of IBS. In Canada,
 accessing dietary treatment for IBS is a challenge due to lack of resources. Some patients
 lack access to dietary interventions, and others are given advice that is not evidenced
 based. Use of eHealth technology, such as virtual education delivered by a dietician, may
 allow for more widespread access to dietary interventions for IBS. Virtual education can
 include one on one dietary education, online group-based education, and the use of apps.
 Currently, there is a gap in knowledge whether dietary intervention for IBS, delivered
 virtually by a dietician, is effective in treating IBS.

ICD-10 Classifications

Irritable bowel syndrome with predominant constipation [IBS-C]
Irritable bowel syndrome
Irritable bowel syndrome with predominant diarrhoea [IBS-D]
Irritable bowel syndrome with mixed bowel habits [IBS-M]
Other and unspecified irritable bowel syndrome

Data Source

ClinicalTrials.gov

NCT05721742

Non-Device Trial